Literature DB >> 12422576

History of the discovery of cyclosporin and of its early pharmacological development.

Jean F Borel1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12422576

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  28 in total

1.  Diversity of monomers in nonribosomal peptides: towards the prediction of origin and biological activity.

Authors:  Ségolène Caboche; Valérie Leclère; Maude Pupin; Gregory Kucherov; Philippe Jacques
Journal:  J Bacteriol       Date:  2010-08-06       Impact factor: 3.490

2.  Expanding the limits of isonitrile-mediated amidations: on the remarkable stereosubtleties of macrolactam formation from synthetic seco-cyclosporins.

Authors:  Xiangyang Wu; Jennifer L Stockdill; Peter K Park; Samuel J Danishefsky
Journal:  J Am Chem Soc       Date:  2012-01-17       Impact factor: 15.419

Review 3.  Immunosuppressive Medications.

Authors:  Alexander C Wiseman
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-13       Impact factor: 8.237

4.  Cyclic Penta- and Hexaleucine Peptides without N-Methylation Are Orally Absorbed.

Authors:  Timothy A Hill; Rink-Jan Lohman; Huy N Hoang; Daniel S Nielsen; Conor C G Scully; W Mei Kok; Ligong Liu; Andrew J Lucke; Martin J Stoermer; Christina I Schroeder; Stephanie Chaousis; Barbara Colless; Paul V Bernhardt; David J Edmonds; David A Griffith; Charles J Rotter; Roger B Ruggeri; David A Price; Spiros Liras; David J Craik; David P Fairlie
Journal:  ACS Med Chem Lett       Date:  2014-08-04       Impact factor: 4.345

Review 5.  Hit and lead criteria in drug discovery for infectious diseases of the developing world.

Authors:  Kei Katsuno; Jeremy N Burrows; Ken Duncan; Rob Hooft van Huijsduijnen; Takushi Kaneko; Kiyoshi Kita; Charles E Mowbray; Dennis Schmatz; Peter Warner; B T Slingsby
Journal:  Nat Rev Drug Discov       Date:  2015-10-05       Impact factor: 84.694

Review 6.  Redox-assisted protein folding systems in eukaryotic parasites.

Authors:  Saikh Jaharul Haque; Tanmay Majumdar; Sailen Barik
Journal:  Antioxid Redox Signal       Date:  2012-01-10       Impact factor: 8.401

7.  Caerulomycin A enhances transforming growth factor-β (TGF-β)-Smad3 protein signaling by suppressing interferon-γ (IFN-γ)-signal transducer and activator of transcription 1 (STAT1) protein signaling to expand regulatory T cells (Tregs).

Authors:  Rama Krishna Gurram; Weshely Kujur; Sudeep K Maurya; Javed N Agrewala
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

Review 8.  Host-targeting agents in the treatment of hepatitis C: a beginning and an end?

Authors:  James M Baugh; Jose A Garcia-Rivera; Philippe A Gallay
Journal:  Antiviral Res       Date:  2013-09-30       Impact factor: 5.970

9.  In vitro study of cyclosporine A 0.05 % on primary and recurrent pterygium fibroblasts.

Authors:  Magda Massae Hata Viveiros; Fabiano Yutaka Kakizaki; Laura Almeida Hércules; Carlos Roberto Padovani; João Manuel Grisi Candeias; Silvana Artioli Schellini
Journal:  Int Ophthalmol       Date:  2015-08-11       Impact factor: 2.031

Review 10.  HCV drug discovery aimed at viral eradication.

Authors:  R F Schinazi; L Bassit; C Gavegnano
Journal:  J Viral Hepat       Date:  2009-12-18       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.